本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Terns Pharmaceuticals, Inc.

7.16
-0.0900-1.24%
成交量:39.43萬
成交額:283.03萬
市值:6.27億
市盈率:-6.87
高:7.32
開:7.24
低:7.07
收:7.25
52周最高:11.40
52周最低:1.87
股本:8,751.10萬
流通股本:5,715.62萬
量比:0.76
換手率:0.69%
股息:- -
股息率:- -
每股收益(TTM):-1.0419
每股收益(LYR):-1.1175
淨資產收益率:-35.02%
總資產收益率:-23.97%
市淨率:2.05
市盈率(LYR):-6.41

資料載入中...

2024/07/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/03

重要事件披露

Form 8-K - Current report
2024/06/12

重要事件披露

Form 8-K - Current report
2024/06/07

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/05/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/13

重要事件披露

Form 8-K - Current report
2024/04/30

重要事件披露

Form 8-K - Current report
2024/04/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/14

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/14

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/14

重要事件披露

Form 8-K - Current report
2024/03/07

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]